Literature DB >> 25515318

Cytometric characterization of circulating tumor cells captured by microfiltration and their correlation to the CellSearch(®) CTC test.

Daniel L Adams1, Steingrimur Stefansson, Christian Haudenschild, Stuart S Martin, Monica Charpentier, Saranya Chumsri, Massimo Cristofanilli, Cha-Mei Tang, R Katherine Alpaugh.   

Abstract

Recent studies reporting hundreds, to thousands, of circulating tumor cells (CTCs) in the blood of cancer patients have raised questions regarding the prevalence of CTCs, as enumerated by the CellSearch(®) CTC Test. Although CellSearch has been shown to consistently detect clinically relevant CTCs; the ability to only capture EpCAM positive cells has led to speculation that it captures limited subsets of CTCs. In contrast, alternative approaches to CTC isolation are often cited as capturing large numbers of CTCs from patient blood. Not surprisingly the number of cells isolated by alternative approaches show poor correlations when compared to CellSearch, even when accounting for EpCAM presence or absence. In an effort to address this discrepancy, we ran an exploratory method comparison study to characterize and compare the CTC subgroups captured from duplicate blood samples from 30 breast and prostate cancer patients using a microfiltration system (CellSieve™) and CellSearch. We then categorized the CellSieve Cytokeratin(CK)+/CD45-/DAPI+ cells into five morphologically distinct subpopulations for correlative analysis. Like other filtration techniques, CellSieve isolated greater numbers of CK+/CD45- cells than CellSearch. Furthermore, analysis showed low correlation between the total CK+/CD45- cells captured by these two assays, regardless of EpCAM presence. However, subgrouping of CK+/CD45-/DAPI+ cells based on distinct cytokeratin staining patterns and nuclear morphologies elucidated a subpopulation correlative to CellSearch. Using method comparison analyses, we identified a specific CTC morphology which is highly correlative between two distinct capture methods. These data suggests that although various morphologic CTCs with similar phenotypic expressions are present in the blood of cancer patients, the clinically relevant cells isolated by CellSearch can potentially be identified using non-EpCAM dependent isolation.
© 2014 The Authors. Published by Wiley Periodicals, Inc. © 2014 The Authors. Published by Wiley Periodicals, Inc. of behalf of ISAC.

Entities:  

Keywords:  CTC cytometry; CellSearch; CellSieve; Circulating Tumor Cells; cancer phenotype characterization; liquid biopsy

Mesh:

Substances:

Year:  2014        PMID: 25515318     DOI: 10.1002/cyto.a.22613

Source DB:  PubMed          Journal:  Cytometry A        ISSN: 1552-4922            Impact factor:   4.355


  53 in total

Review 1.  Extracellular vesicles such as prostate cancer cell fragments as a fluid biopsy for prostate cancer.

Authors:  S I Brett; Y Kim; C N Biggs; J L Chin; H S Leong
Journal:  Prostate Cancer Prostatic Dis       Date:  2015-05-12       Impact factor: 5.554

2.  Reduced-Intensity Haploidentical Bone Marrow Transplantation with Post-Transplant Cyclophosphamide for Solid Tumors in Pediatric and Young Adult Patients.

Authors:  Nicolas J Llosa; Kenneth R Cooke; Allen R Chen; Christopher J Gamper; Orly R Klein; Elias T Zambidis; Brandon Luber; Gary Rosner; Nicholas Siegel; Mary Jo Holuba; Nancy Robey; Masanori Hayashi; Richard J Jones; Ephraim Fuchs; Matthias Holdhoff; David M Loeb; Heather J Symons
Journal:  Biol Blood Marrow Transplant       Date:  2017-08-12       Impact factor: 5.742

3.  Detection of circulating tumour cells and their potential use as a biomarker for advanced renal cell carcinoma.

Authors:  Tae Heon Kim; Yoon-Tae Kang; Young-Ho Cho; Jeong Hoon Kim; Byong Chang Jeong; Seong Il Seo; Seong Soo Jeon; Hyun Moo Lee
Journal:  Can Urol Assoc J       Date:  2019-01-21       Impact factor: 1.862

Review 4.  Phenotype of circulating tumor cell: face-off between epithelial and mesenchymal masks.

Authors:  Yupeng Hong; Qi Zhang
Journal:  Tumour Biol       Date:  2016-01-13

Review 5.  Improving pancreatic cancer diagnosis using circulating tumor cells: prospects for staging and single-cell analysis.

Authors:  Colin M Court; Jacob S Ankeny; Shuang Hou; Hsian-Rong Tseng; James S Tomlinson
Journal:  Expert Rev Mol Diagn       Date:  2015-09-21       Impact factor: 5.225

Review 6.  Circulating tumor cell technologies.

Authors:  Meghaan M Ferreira; Vishnu C Ramani; Stefanie S Jeffrey
Journal:  Mol Oncol       Date:  2016-01-28       Impact factor: 6.603

7.  Precision Microfilters as an all in one System for Multiplex Analysis of Circulating Tumor Cells.

Authors:  Daniel L Adams; R Katherine Alpaugh; Stuart S Martin; Monica Charpentier; Saranya Chumsri; Massimo Cristofanilli; Diane K Adams; Olga V Makarova; Peixuan Zhu; Shuhong Li; Cha-Mei Tang; Steingrimur Stefansson
Journal:  RSC Adv       Date:  2016-01-11       Impact factor: 3.361

8.  Circulating Cancer-Associated Macrophage-Like Cells Differentiate Malignant Breast Cancer and Benign Breast Conditions.

Authors:  Daniel L Adams; Diane K Adams; R Katherine Alpaugh; Massimo Cristofanilli; Stuart S Martin; Saranya Chumsri; Cha-Mei Tang; Jeffrey R Marks
Journal:  Cancer Epidemiol Biomarkers Prev       Date:  2016-05-17       Impact factor: 4.254

Review 9.  Tracking metastatic breast cancer: the future of biology in biosensors.

Authors:  Y C Lim; A P Wiegmans
Journal:  Med Oncol       Date:  2016-03-19       Impact factor: 3.064

Review 10.  Circulating Tumor Cell and Cell-free Circulating Tumor DNA in Lung Cancer.

Authors:  Fariz Nurwidya; Jamal Zaini; Andika Chandra Putra; Sita Andarini; Achmad Hudoyo; Elisna Syahruddin; Faisal Yunus
Journal:  Chonnam Med J       Date:  2016-09-23
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.